Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects
by
Zoghbi, Huda Y.
, Barupal, Dinesh K.
, Gatchel, Jennifer R.
, Kaddurah-Daouk, Rima
, Fiehn, Oliver
, Perroud, Bertrand
, Wang, Lu
, Wikoff, William R.
, Crespo-Barreto, Juan
, Jafar-Nejad, Paymaan
in
Amino acids
/ Analysis
/ Animals
/ Annotations
/ Antigens, Ly - physiology
/ Antipsychotic Agents - pharmacology
/ Ascorbic acid
/ Ataxia
/ Ataxin
/ Biology
/ Biomarkers - metabolism
/ Biosynthesis
/ Brain research
/ Cerebellum
/ Cerebellum - metabolism
/ Chemistry
/ Children & youth
/ Disease
/ Disease Models, Animal
/ Energy metabolism
/ Fatty acids
/ Female
/ Gas chromatography
/ Gas Chromatography-Mass Spectrometry
/ Genomes
/ Genotypes
/ Hospitals
/ Kinases
/ Lipid metabolism
/ Lipids
/ Lithium
/ Lithium - pharmacology
/ Male
/ Mass spectrometry
/ Mass spectroscopy
/ Mathematics
/ Medicine
/ Membrane Proteins - physiology
/ Metabolic pathways
/ Metabolism
/ Metabolites
/ Metabolome - drug effects
/ Metabolomics
/ Mice
/ Mice, Inbred C57BL
/ Mice, Knockout
/ Neurodegeneration
/ Neuroprotection
/ Oxidative stress
/ Pathogenesis
/ Pharmacology
/ Proteins
/ Purines
/ Rodents
/ Spinocerebellar ataxia
/ Sterols
/ Sulfur
/ Tricarboxylic acid cycle
2013
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects
by
Zoghbi, Huda Y.
, Barupal, Dinesh K.
, Gatchel, Jennifer R.
, Kaddurah-Daouk, Rima
, Fiehn, Oliver
, Perroud, Bertrand
, Wang, Lu
, Wikoff, William R.
, Crespo-Barreto, Juan
, Jafar-Nejad, Paymaan
in
Amino acids
/ Analysis
/ Animals
/ Annotations
/ Antigens, Ly - physiology
/ Antipsychotic Agents - pharmacology
/ Ascorbic acid
/ Ataxia
/ Ataxin
/ Biology
/ Biomarkers - metabolism
/ Biosynthesis
/ Brain research
/ Cerebellum
/ Cerebellum - metabolism
/ Chemistry
/ Children & youth
/ Disease
/ Disease Models, Animal
/ Energy metabolism
/ Fatty acids
/ Female
/ Gas chromatography
/ Gas Chromatography-Mass Spectrometry
/ Genomes
/ Genotypes
/ Hospitals
/ Kinases
/ Lipid metabolism
/ Lipids
/ Lithium
/ Lithium - pharmacology
/ Male
/ Mass spectrometry
/ Mass spectroscopy
/ Mathematics
/ Medicine
/ Membrane Proteins - physiology
/ Metabolic pathways
/ Metabolism
/ Metabolites
/ Metabolome - drug effects
/ Metabolomics
/ Mice
/ Mice, Inbred C57BL
/ Mice, Knockout
/ Neurodegeneration
/ Neuroprotection
/ Oxidative stress
/ Pathogenesis
/ Pharmacology
/ Proteins
/ Purines
/ Rodents
/ Spinocerebellar ataxia
/ Sterols
/ Sulfur
/ Tricarboxylic acid cycle
2013
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects
by
Zoghbi, Huda Y.
, Barupal, Dinesh K.
, Gatchel, Jennifer R.
, Kaddurah-Daouk, Rima
, Fiehn, Oliver
, Perroud, Bertrand
, Wang, Lu
, Wikoff, William R.
, Crespo-Barreto, Juan
, Jafar-Nejad, Paymaan
in
Amino acids
/ Analysis
/ Animals
/ Annotations
/ Antigens, Ly - physiology
/ Antipsychotic Agents - pharmacology
/ Ascorbic acid
/ Ataxia
/ Ataxin
/ Biology
/ Biomarkers - metabolism
/ Biosynthesis
/ Brain research
/ Cerebellum
/ Cerebellum - metabolism
/ Chemistry
/ Children & youth
/ Disease
/ Disease Models, Animal
/ Energy metabolism
/ Fatty acids
/ Female
/ Gas chromatography
/ Gas Chromatography-Mass Spectrometry
/ Genomes
/ Genotypes
/ Hospitals
/ Kinases
/ Lipid metabolism
/ Lipids
/ Lithium
/ Lithium - pharmacology
/ Male
/ Mass spectrometry
/ Mass spectroscopy
/ Mathematics
/ Medicine
/ Membrane Proteins - physiology
/ Metabolic pathways
/ Metabolism
/ Metabolites
/ Metabolome - drug effects
/ Metabolomics
/ Mice
/ Mice, Inbred C57BL
/ Mice, Knockout
/ Neurodegeneration
/ Neuroprotection
/ Oxidative stress
/ Pathogenesis
/ Pharmacology
/ Proteins
/ Purines
/ Rodents
/ Spinocerebellar ataxia
/ Sterols
/ Sulfur
/ Tricarboxylic acid cycle
2013
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects
Journal Article
Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects
2013
Request Book From Autostore
and Choose the Collection Method
Overview
We have shown that lithium treatment improves motor coordination in a spinocerebellar ataxia type 1 (SCA1) disease mouse model (Sca1(154Q/+)). To learn more about disease pathogenesis and molecular contributions to the neuroprotective effects of lithium, we investigated metabolomic profiles of cerebellar tissue and plasma from SCA1-model treated and untreated mice. Metabolomic analyses of wild-type and Sca1(154Q/+) mice, with and without lithium treatment, were performed using gas chromatography time-of-flight mass spectrometry and BinBase mass spectral annotations. We detected 416 metabolites, of which 130 were identified. We observed specific metabolic perturbations in Sca1(154Q/+) mice and major effects of lithium on metabolism, centrally and peripherally. Compared to wild-type, Sca1(154Q/+) cerebella metabolic profile revealed changes in glucose, lipids, and metabolites of the tricarboxylic acid cycle and purines. Fewer metabolic differences were noted in Sca1(154Q/+) mouse plasma versus wild-type. In both genotypes, the major lithium responses in cerebellum involved energy metabolism, purines, unsaturated free fatty acids, and aromatic and sulphur-containing amino acids. The largest metabolic difference with lithium was a 10-fold increase in ascorbate levels in wild-type cerebella (p<0.002), with lower threonate levels, a major ascorbate catabolite. In contrast, Sca1(154Q/+) mice that received lithium showed no elevated cerebellar ascorbate levels. Our data emphasize that lithium regulates a variety of metabolic pathways, including purine, oxidative stress and energy production pathways. The purine metabolite level, reduced in the Sca1(154Q/+) mice and restored upon lithium treatment, might relate to lithium neuroprotective properties.
Publisher
Public Library of Science,Public Library of Science (PLoS)
This website uses cookies to ensure you get the best experience on our website.